Concepedia

J‐L Moreau

JM

Statistics

Publications

6

Citations

636

H-Index

6

Active since

1997

Affiliations

Roche (Switzerland)(Current)

J‐L Moreau is an author at Roche (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

1997–2014

6

Publications

6

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

F. Revel, J‐L Moreau, Bruno Pouzet et al. · Molecular Psychiatry · 2012 · 286 citations

, , +16

Pathological brain plasticity and cognition in the offspring of males subjected to postnatal traumatic stress

Johannes Bohacek, M Farinelli, Osvaldo Mirante et al. · Molecular Psychiatry · 2014 · 117 citations

, , +14

Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX<sub>2</sub> receptor

P. Malherbe, Edilio Borroni, Luca Gobbi et al. · British Journal of Pharmacology · 2009 · 93 citations · Full text

, , +17

The role of 5ht2c receptors in affective disorders

F. Jenck, Michael Bös, J. Wichmann et al. · Expert Opinion on Investigational Drugs · 1998 · 67 citations

, , +17

Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT2C receptor

Michael Bös, F. Jenck, J‐L Moreau et al. · European Journal of Medicinal Chemistry · 1997 · 44 citations

, , +11

1–5 of 6